v3.25.4
Consolidated Balance Sheet - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 1,116 $ 1,738
Inventories 5,097 3,995
Prepaid expenses and other current assets 1,287 1,144
Total Current Assets 17,271 17,910
Investments and long-term receivables 11,905 14,378
Net properties, plants and equipment 39,097 35,264
Goodwill 1,433 1,575
Intangibles 978 1,161
Other assets 2,996 2,294
Total Assets 73,680 72,582
Liabilities    
Short-term debt 1,038 1,831
Accrued income and other taxes 1,362 1,060
Employee benefit obligations 680 732
Other accruals 1,379 1,160
Total Current Liabilities 13,326 15,087
Long-term debt 18,678 18,231
Asset retirement obligations and accrued environmental costs 1,022 1,129
Deferred income taxes 7,308 7,101
Employee benefit obligations 573 703
Other liabilities and deferred credits 2,532 1,868
Total Liabilities 43,439 44,119
Equity    
Common stock (2,500,000,000 shares authorized at $0.01 par value) Issued (2025—656,987,861 shares; 2024—654,842,101 shares) Par value 7 7
Capital in excess of par 19,948 19,788
Treasury stock (at cost: 2025—258,252,603 shares; 2024—248,594,923 shares) (23,934) (22,751)
Retained earnings 33,239 30,771
Accumulated other comprehensive loss (167) (407)
Total Stockholders’ Equity 29,093 27,408
Noncontrolling interests 1,148 1,055
Total Equity 30,241 28,463
Total Liabilities and Equity 73,680 72,582
Nonrelated Party    
Assets    
Accounts and notes receivable (net of allowances of $68 million in 2025 and $70 million in 2024) 9,158 9,544
Liabilities    
Accounts payable 8,581 9,792
Related Party    
Assets    
Accounts and notes receivable (net of allowances of $68 million in 2025 and $70 million in 2024) 613 1,489
Liabilities    
Accounts payable $ 286 $ 512